Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060120) titled 'The effectiveness of 19G FNA and 22G FNB needle for diagnosing lymphadenopathy' on Jan. 1.
Study Type:
Observational
Primary Sponsor:
Institute - other
Condition:
Condition - mediastinal or abdominal lymphadenopathy
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the usefulness of 19G FNA and 22G FNB needles for lymphadenopathy diagnosis
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Female
Key inclusion criteria - >17-years-old
EUS-FNA performed cases with mediastinal or abdominal lymphadenopathy using 19...